The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Angiotensin-converting Enzyme Degrades Alzheimer Amyloid β-Peptide (Aβ); Retards Aβ Aggregation, Deposition, Fibril Formation; and Inhibits Cytotoxicity
Open accessAbstract
We have demonstrated that the angiotensin-converting enzyme (ACE) genotype is associated with Alzheimer's disease (AD) in the Japanese population (). To determine why ACE affects susceptibility to AD, we examined the effect of purified ACE on aggregation of the amyloid beta-peptide (A beta) in vitro. Surprisingly, ACE was found to significantly inhibit A beta aggregation in a dose response manner. The inhibition of aggregation was specifically blocked by preincubation of ACE with an ACE inhibitor, lisinopril. ACE was confirmed to retard A beta fibril formation with electron microscopy. ACE inhibited A beta deposits on a synthaloid plate, which was used to monitor A beta deposition on autopsied brain tissue. ACE also significantly inhibited A beta cytotoxicity on PC12 h. The most striking fact was that ACE degraded A beta by cleaving A beta-(1-40) at the site Asp(7)-Ser(8). This was proven with reverse-phase HPLC, amino acid sequence analysis, and MALDI-TOF/MS. Compared with A beta-(1-40), aggregation and cytotoxic effects of the degradation products A beta-(1-7) and A beta-(8-40) peptides were reduced or virtually absent. These findings led to the hypothesis that ACE may affect susceptibility to AD by degrading A beta and preventing the accumulation of amyloid plaques in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114844 · Cited by 3,767
Levine, H. (1993) · Protein Science · doi:10.1002/pro.5560020312 · Cited by 2,264
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Genetic associations with human longevity at the APOE and ACE loci
Schächter, F., Faure-Delanef, L., Guénot, F., Rouger, H., Froguel, P., Lesueur-Ginot, L., & Cohen, D. (1994) · Nature Genetics · doi:10.1038/ng0194-29 · Cited by 1,095
Elevation of serum angiotension-converting-enzyme (ACE) level in sarcoidosis
Lieberman, J. (1975) · The American Journal of Medicine · doi:10.1016/0002-9343(75)90395-2 · Cited by 870
Iwata, N., Tsubuki, S., Takaki, Y., Watanabe, K., Sekiguchi, M., Hosoki, E., Kawashima-Morishima, M., Lee, H.-J., Hama, E., Sekine-Aizawa, Y., et al. (2000) · Nature Medicine · doi:10.1038/72237 · Cited by 867
In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity
Pike, C. J., Walencewicz, A. J., Glabe, C. G., & Cotman, C. W. (1991) · Brain Research · doi:10.1016/0006-8993(91)91553-d · Cited by 828
Normal and Abnormal Biology of the beta-Amyloid Precursor Protein
Selkoe, D. J. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.002421 · Cited by 818
Ishiyama, M. (1997) · Talanta · doi:10.1016/s0039-9140(97)00017-9 · Cited by 687
Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease
Hilbich, C., Kisters-Woike, B., Reed, J., Masters, C. L., & Beyreuther, K. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90881-6 · Cited by 580
Regulation of APP cleavage by α‐, β‐ and γ‐secretases
Nunan, J., & Small, D. H. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02076-7 · Cited by 512
Shearman, M. S., Ragan, C. I., & Iversen, L. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1470 · Cited by 412
Self-association of β-Amyloid Peptide (1–40) in Solution and Binding to Lipid Membranes
Terzi, E., Hölzemann, G., & Seelig, J. (1995) · Journal of Molecular Biology · doi:10.1006/jmbi.1995.0525 · Cited by 306
Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease
Kehoe, P. G., Russ, C., McIlroy, S., Williams, H., Holmans, P., Holmes, C., Liolitsa, D., Vahidassr, D., Powell, J., McGleenon, B., et al. (1999) · Nature Genetics · doi:10.1038/5009 · Cited by 260
Colorimetry of angiotensin-I converting enzyme activity in serum.
Kasahara, Y., & Ashihara, Y. (1981) · Clinical Chemistry · doi:10.1093/clinchem/27.11.1922 · Cited by 244
Skoog, I., Wallin, A., Fredman, P., Hesse, C., Aevarsson, O., Karlsson, I., Gottfries, C. G., & Blennow, K. (1998) · Neurology · doi:10.1212/wnl.50.4.966 · Cited by 241
Regulation of Amyloid Precursor Protein Cleavage
Mills, J., & Reiner, P. B. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720443.x · Cited by 221
The Role of APP Processing and Trafficking Pathways in the Formation of Amyloid β‐Proteina
SELKOE, D. J., YAMAZAKI, T., CITRON, M., PODLISNY, M. B., KOO, E. H., TEPLOW, D. B., & HAASS, C. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34401.x · Cited by 205
Contributions of the Brain Angiotensin IV–AT4Receptor Subtype System to Spatial Learning
Wright, J. W., Stubley, L., Pederson, E. S., Kramár, E. A., Hanesworth, J. M., & Harding, J. W. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-03952.1999 · Cited by 182
Impaired blood–brain barrier function in angiotensinogen-deficient mice
Kakinuma, Y., Hama, H., Sugiyama, F., Yagami, K., Goto, K., Murakami, K., & Fukamizu, A. (1998) · Nature Medicine · doi:10.1038/2070 · Cited by 160
Amyloid Fibril Toxicity in Alzheimer's Disease and Diabetesa
Lorenzo, A., & Yankner, B. A. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34406.x · Cited by 151
Mapping tissue angiotensin-converting enzyme and angiotensin AT1, AT2 and AT4 receptors
Zhuo, J. L., Moeller, I., Jenkins, T. A., Chai, S. Y., Allen, A. M., Ohishi, M., & Mendelsohn, F. A. O. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816121-00026 · Cited by 131
Angiotensin II- and IV-induced changes in cerebral blood flow
Kramár, E. A., Harding, J. W., & Wright, J. W. (1997) · Regulatory Peptides · doi:10.1016/s0167-0115(96)02116-7 · Cited by 128
In Vitro Growth of Alzheimer's Disease β-Amyloid Plaques Displays First-Order Kinetics †
Esler, W. P., Stimson, E. R., Ghilardi, J. R., Vinters, H. V., Lee, J. P., Mantyh, P. W., & Maggio, J. E. (1996) · Biochemistry · doi:10.1021/bi951685w · Cited by 128
Reardon, K. A., Mendelsohn, F. A. O., Chai, S. Y., & Horne, M. K. (2000) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.2000.tb01054.x · Cited by 117
Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog
Pederson, E. S., Harding, J. W., & Wright, J. W. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00028-7 · Cited by 104
Chesneau, V., Vekrellis, K., Rosner, M. R., & Selkoe, D. J. (2000) · Biochemical Journal · doi:10.1042/bj3510509 · Cited by 101
Álvarez, R., Álvarez, V., Lahoz, C. H., Martinez, C., Pena, J., Sanchez, J. M., Guisasola, L. M., Salas‐Puig, J., Morís, G., Vidal, J. A. C., et al. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.6.733 · Cited by 98
Association Between Angiotensin-Converting Enzyme and Alzheimer Disease
Farrer, L. A., Sherbatich, T., Keryanov, S. A., Коровайцева, Г. И., Rogaeva, E. A., Petruk, S., Premkumar, S., Moliaka, Y., Song, Y., Pei, Y., et al. (2000) · Archives of Neurology · doi:10.1001/archneur.57.2.210 · Cited by 94
Hu, J., Miyatake, F., Aizu, Y., Nakagawa, H., Nakamura, S., Tamaoka, A., Takahash, R., Urakami, K., & Shoji, M. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00827-7 · Cited by 72
Self-citationAβ deposition inhibitor screen using synthetic amyloid
Esler, W. P., Stimson, E. R., Ghilardi, J. R., Felix, A. M., Lu, Y., Vinters, H. V., Mantyh, P. W., & Maggio, J. E. (1997) · Nature Biotechnology · doi:10.1038/nbt0397-258 · Cited by 70
Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease
Crawford, F., Abdullah, L. I., Schinka, J. A., Suo, Z., Gold, M., Duara, R., & Mullan, M. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00791-6 · Cited by 56
Anti-apoptotic action of angiotensin fragments to neuronal cells from angiotensinogen knock-out mice
Kakinuma, Y., Hama, H., Sugiyama, F., Goto, K., Murakami, K., & Fukamizu, A. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00605-8 · Cited by 48
Small, D. H. (1998) · Neurochemical Research · doi:10.1023/a:1022471729291 · Cited by 40
Commentary and perspective on studies of beta amyloid neurotoxicity
Yankner, B. A. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90067-8 · Cited by 39
Inhibition of β-amyloid cytotoxicity by midkine
Yu, G. S. P., Hu, J., & Nakagawa, H. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00685-5 · Cited by 29
Self-citation
Cited by
Amyloid Beta: Structure, Biology and Structure-Based Therapeutic Development
Chen, G.-F., Xu, T.-H., Yan, Y., Zhou, Y.-R., Jiang, Y., Melcher, K., & Xu, H. E. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.28 · Cited by 1,965
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 882
The Genetics of Alzheimer's Disease
Bertram, L., & Tanzi, R. E. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-385883-2.00008-4 · Cited by 760
Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Bertram, L., & Tanzi, R. E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2494 · Cited by 747
The genetics of Alzheimer disease
Tanzi, R. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006296 · Cited by 727
Metadata
- Authors
- Hu, J., Igarashi, A., Kamata, M., & Nakagawa, H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-12
- Volume
- 276
- Issue
- 51
- Pages
- 47863-47868
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1569630040
- Cited by
- 360
- References
- 37
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.